DEA

The DEA reported an uptick in cannabis arrests and seizures for last year, marking the highest federal enforcement figures since 2011.

Police arrested activists outside of the headquarters of the DEA as they protested the agency’s refusal to let terminally ill patients access experimental drugs like psilocybin and MDMA.

Maridose LLC, based in Florida, is close to obtaining DEA approval to cultivate cannabis for research purposes in Maine.

While a recent DEA letter appeared to suggest that cannabis material containing less than 0.3% THC is federally legal under the 2018 Farm Bill, legal experts still caution against sending seeds, clones, and other byproducts by mail.

The DEA will recognize cannabis seeds as legal products under the 2018 Farm Bill so long as the seeds themselves do not exceed the 0.3% THC limit.

Two companies have accused the DEA of delaying the application process for bulk cannabis manufacturing in the production of cannabinoid-based pharmaceuticals.

A U.S. House proposal is seeking to reform the 2018 Farm Bill by increasing THC limits in hemp products, removing DEA lab testing requirements, and eliminating drug-related licensing restrictions.

Groff North America Hemplex and BRC, two cannabis cultivation firms, have harvested federally sanctioned cannabis for research purposes, ending a 50-year monopoly by the University of Mississippi.

A recently surfaced letter by a high-ranking DEA official may have hinted that the agency considers delta-8 THC products synthesized from hemp extracts to be federally legal.

A cannabis cash transport company is seeking the return of $166,000 that was seized by police in partnership with the DEA who said they had detected a “marijuana odor.”

Bank of America suddenly canceled the account of cannabis research firm Scottsdale Research Institute despite being fully compliant with federal laws and operating with public DEA approval.

The DEA has proposed massively increasing the production of research-grade cannabis and psychedelics like LSD, psilocybin, and MDMA next year.

The DEA last week called for a significant increase in the production of cannabis and psilocybin for the purposes of federal research and clinical trials.

A former DEA special agent was sentenced to 13 years in prison on Thursday for crimes including perjury, obstruction of justice, and theft.

The DEA informed some companies on Friday it was prepared to approve their cannabis research cultivation applications. The move will ultimately end the University of Mississippi’s decades-long monopoly on research-grade cannabis.

The DEA published a new rule on Thursday that will allow researchers to apply to cultivate cannabis for research purposes.

Cannabis researcher Dr. Lyle Craker has filed suit over the DEA’s failure to license additional growers for research-grade cannabis.

The DEA is seeking a contractor capable of incinerating up to 8,000 pounds of cannabis and other federally prohibited substances per day.

MAPS, the Multidisciplinary Association of Psychedelic Studies, issued a public response to the DEA’s repeatedly delayed licensing of additional research-grade cannabis growers.

Federal investigators with the FBI and DEA have partnered with Maine State Police to investigate two companies operating in the cannabis space.

Lawmakers in the House of Representatives have advanced a highways infrastructure bill that includes language making products from state-legal cannabis markets available for federal research purposes.

The DEA has requested and received permission to investigate and police people taking part in the ongoing protests over the death of George Floyd.

The DEA has removed Epidiolex, the CBD-based epilepsy medication made by GW Pharmaceuticals, from the federal controlled substances list.

The DEA has unveiled a new rule proposal that would finally open up the licensing of new research-grade cannabis cultivators.